Jianqiang Li

Immunomodulation(GRK 520)

Institute of Virology and Immunology
Versbacher Str. 7
97078 Würzburg

Phone +49 (0) 931 201-49643
limmune@gmail.com

Thesis Project

Modulating the expression of enzymes of isoprenoid synthesis: effects on Vγ9Vδ2 T cell activation and tumor cell growth

Supervisors

Thomas Herrmann (direct supervisor)
Roland Benz
Alexander Steinle

Project Abstract

Vγ9Vδ2 T T cells are neither MHC-restricted nor peptide-specific. Natural occurring antigens of Vγ9Vδ2 T cells are metabolites of the isoprenoid syntheses, such as the ubiquitous isopentenyl pyrophosphate (IPP).
Aminobisphosphonates inhibit farnesyl pyrophosphate (FPP) synthase, an IPP consuming enzyme. To explain their Vγ9Vδ2 T cell-activating features, it has been suggested that inhibition of FPP synthase leads to an increase of IPP in tumor cells, which then would activate tumor-specific Vγ9Vδ2 T cells. Some tumor cell lines, such as the B-cell lymphoma Daudi, can be even directly recognized by Vγ9Vδ2 cells. Two hypotheses have been put forward to explain their recognition by Vγ9Vδ2 T cells. 1) The Vγ9Vδ2 TCR binds to an ectopically-expressed F1 ATPase, 2) Vγ9Vδ2 T cells sense an abnormally high level of IPP found in these special tumors.
So far concepts on recognition of (aminobisphosphonate-treated) tumors by Vγ9Vδ2  T cells are based on studies analyzing Vγ9Vδ2 T cell recognition in the presence or absence of inhibitors of the mevalonate pathway of isoprenoid synthesis such as statins (inhibitors of HMG-CoA reductase) or aminobisphosphonates (inhibitor of FPP synthase). We want to use alternative methods to evaluate these concepts. To this end, FPP synthase will be over-expressed (by RT-PCR cloning of FPP synthase into a bicistronic retroviral vector and subsequent retroviral transfer in tumor cells) or modulated (via a tet on/off system or RNAi) in tumor cells. Overexpression would be expected to lower IPP levels and reduce recognition by Vγ9Vδ2 T cells. Inhibition should increase IPP concentration and mimic effects of amino bisphosphonates. Thereafter, these modified tumor cells will be cultured and analysed for Vγ9Vδ2 T cell-activating properties (Cr51 release/induction of TNF release by Vγ9Vδ2 T cell lines/induction of IL-2 production by Vγ9Vδ2 TCR transduced cells) and also for growth (3H-TdR uptake) and death (annexin V staining, propidium iodide staining), expression of NKG2D ligands (staining with NKG2D dimers), effects of ras prenylation (Western-blot), FPP synthase activity.  Depending on these results, other enzymes of the metabolic pathway will also be evaluated.

Publication

 

Presentation

Poster: “Reduced expression of the mevalonate pathway enzyme farnesyl pyrophosphate synthase unveils recognition of tumor cells by Vg9Vd2 T cells” Doctoral Students Symposium 2009, Würzburg

 

Last update 06 April 2009 E. Drescher